Vahdat, Linda T.

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature

Cancer Cells and MetastasisTGF-β signaling in diseases

Cited by 1,791

Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study

Cortes, J., O'Shaughnessy, J., Loesch, D., Blum, J. L., Vahdat, L. T., Petrakova, K., Chollet, P., Manikas, A., Diéras, V., Delozier, T., et al. (2011) · The Lancet

Cancer Treatment and PharmacologyBreast Cancer Treatment Studies

Cited by 1,094

Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer

Bardia, A., Mayer, I. A., Vahdat, L. T., Tolaney, S. M., Isakoff, S. J., Diamond, J. R., O’Shaughnessy, J., Moroose, R. L., Santin, A. D., Abramson, V. G., et al. (2019) · New England Journal of Medicine

Breast Cancer Treatment StudiesAdvanced Breast Cancer Therapies

Cited by 874

Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

Petrelli, N. J., Winer, E. P., Brahmer, J., Dubey, S., Smith, S., Thomas, C., Vahdat, L. T., Obel, J., Vogelzang, N., Markman, M., et al. (2009) · Journal of Clinical Oncology

Science, Research, and MedicineHealth and Medical Research Impacts

Cited by 121

Menopause is a determinant of breast adipose inflammation

Iyengar, N. M., Morris, P. G., Zhou, X. K., Gucalp, A., Giri, D., Harbus, M. D., Falcone, D. J., Krasne, M. D., Vahdat, L. T., Subbaramaiah, K., et al. (2015) · Cancer Prevention Research

Adipokines, Inflammation, and Metabolic DiseasesEstrogen and related hormone effects

Cited by 106